Quick answers
- What is Fluorescein sodium and benoxinate hydrochloride used for?
- The FDA-approved label (Altafluor, Altaire Pharmaceuticals Inc., December 6, 2017) says: “Altafluor Benox (fluorescein sodium and benoxinate hydrochloride ophthalmic solution) 0.25%/0.4% is indicated for ophthalmic procedures requiring a disclosing agent in combination with a topical ophthalmic anesthetic agent. …” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- Does Fluorescein sodium and benoxinate hydrochloride have a boxed warning?
- No. None of the 3 FDA labels we found for this medicine has a boxed warning.
- Is there a shortage of Fluorescein sodium and benoxinate hydrochloride?
- No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
- Has Fluorescein sodium and benoxinate hydrochloride been recalled?
- No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
- Who makes Fluorescein sodium and benoxinate hydrochloride?
- 3 companies list prescription products of Fluorescein sodium and benoxinate hydrochloride in the FDA NDC Directory, including Altaire Pharmaceuticals Inc., Bausch & Lomb Americas Inc. and Bausch & Lomb Incorporated.
What Fluorescein sodium and benoxinate hydrochloride is used for
Quoted from the “Indications and Usage” section of the FDA-approved label.
Altafluor Benox (fluorescein sodium and benoxinate hydrochloride ophthalmic solution) 0.25%/0.4% is indicated for ophthalmic procedures requiring a disclosing agent in combination with a topical ophthalmic anesthetic agent. …
— FDA label: Altafluor, Altaire Pharmaceuticals Inc., effective December 6, 2017. Read the full label on DailyMed →
The FDA has 3 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Boxed warning
A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.
The label quoted above has no boxed warning.
0 of 3 FDA labels for this medicine have a boxed warning.
Forms and how it is given
| Dosage forms | Solution/ drops · Solution |
|---|---|
| Route | Ophthalmic |
| Prescription products | 3 in the FDA NDC Directory |
| Brand names | Altafluor |
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- Altaire Pharmaceuticals Inc.1 product
- Bausch & Lomb Americas Inc.1 product
- Bausch & Lomb Incorporated1 product
FDA approval history
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
Shortage status
The FDA drug shortage list does not show these products.
Recalls
No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.
Official identifiers
| RxCUI (RxNorm) | 2099132, 2099522, 2287005 |
|---|---|
| SPL set ID of the quoted label | 54017304-e680-4129-b52a-69cb9810af76 |
| FDA labels (SPL) | 3 |
| FDA applications | NDA208582, NDA211039 |
| Active ingredients (FDA) | BENOXINATE / FLUORESCEIN |
Sources
- FDA-approved label on DailyMed (National Library of Medicine) — Altafluor, Altaire Pharmaceuticals Inc., effective December 6, 2017; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →